Clinicians at Halifax’s IWK Health Centre are reporting a troubling rise in the number of young patients presenting with severe, cannabis-related psychiatric symptoms. Medical professionals note that these cases are not only increasing in frequency but are also characterized by symptoms that persist for extended periods, even after the individual has ceased using the drug.
Dr. Kyle Godden, an inpatient psychiatrist at the IWK, observed that youth who consume high-potency cannabis products often experience more acute episodes that necessitate prolonged hospital stays. In one instance, a young patient was admitted suffering from severe paranoia, agitation, and hallucinations. Upon recovery, the patient expressed that he had been unaware of the extreme strength of the product he had consumed.
The Risks of High-Potency THC
The trend of rising hospitalizations mirrors a decade-long increase in the concentration of THC, the primary mind-altering compound in cannabis. Dr. Sabina Abidi, head of the Youth Psychosis Clinic at the IWK, points to a clear correlation between THC concentrations of 10 per cent or higher and impairments in focus, motivation, and driving capabilities. She warns that these products can trigger serious and persistent psychiatric illnesses.
Did You Know?
Health Canada officially warns that cannabis products containing THC concentrations exceeding 20 per cent significantly elevate the risk of long-term mental health issues and harmful side effects.
Preliminary data from an ongoing study by Dr. Abidi indicates a striking upward trend in hospital cases. Within the last month alone, she has treated five individuals for psychotic symptoms directly linked to high-potency cannabis—a figure that represents double the volume of similar cases seen just five years ago. For youth with a family history of schizophrenia or psychosis, these products can serve as a dangerous psychological trigger.
Expert Insight:
The comparison of the current high-potency market to the “nicotine story of the ’60s” serves as a stark reminder of how rapidly public health crises can evolve when consumer awareness lags behind product innovation. The core challenge here is the intersection of accessibility and extreme potency, which may require a re-evaluation of how society monitors and regulates the availability of these substances to protect vulnerable youth.
The Path Forward
Medical experts are calling for urgent public health interventions to prevent youth from accessing high-potency items, which can reach concentrations as high as 90 per cent. While provincial authorities have already begun efforts to curb illegal dispensaries, clinicians suggest that further government protections may be necessary to address the risks posed by online and other illicit sources.
Looking ahead, it is likely that public health officials will continue to advocate for increased awareness among parents regarding the risks of vape pens and “dab” products. If current trends in THC concentration continue, hospitals may face an ongoing strain on resources as they manage the long-term psychiatric impacts of these potent substances on the youth population.
Frequently Asked Questions
Why are symptoms taking longer to clear in young patients?
Clinicians at the IWK have observed that the use of high-potency cannabis products leads to more severe episodes, which inherently require longer hospital care and recovery times compared to lower-potency alternatives.
What is the connection between THC levels and psychiatric issues?
According to experts, THC concentrations of 10 per cent or higher are linked to impairments in focus and motivation. High-potency THC can trigger serious, persistent psychiatric illnesses, particularly in youth with a family history of psychosis or schizophrenia.
Are these products legal for youth?
No. It is illegal for individuals under the age of 19 to purchase these cannabis products. However, health professionals note that youth are still accessing them through online sources and other illegal channels.
How can parents better navigate conversations with their children about the risks of high-potency cannabis in an increasingly complex market?
